Lexaria CEO Chris Bunka on the Latest Cannabinoid Patents With Big Potential Revenue Streams
2,187 views · Published 2 February 2018 · 6:54 · Indexed 28 October 2026
Channel: Midas Letter · 2018 · Education
Lexaria Bioscience Corp (CNSX:LXX) (OTCMKTS:LXRP) is a drug delivery platform innovator. CEO Chris Bunka talks about the company's new patent which covers new cannabinoids and other ingestible molecules delivery platform, as well as its DehydraTECH™ technology, which improves tastes and the rapidity in which a drug reaches your blood stream. The nicotine space is seen as one of the biggest opportunities for Lexaria products. ************************ LINK: http://bit.ly/LexariaPatent ************************ Check out our website: https://MidasLetter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************
More from this channel
-
6:13
Green Relief Inc CEO Warren Bravo on Growing Cannabis Using Fish
-
6:53
Crown Mining Corp (CVE:CWM) Director on Partnerships and Permitting for California Copper Projects
-
6:42
GreenBank CEO Danny Wettreich on Investing in Ubique and Blockchain Evolution
-
0:12
Hey Welcome to MIdas Letter!
-
8:42
MedReleaf CEO Neil Closner on the Recent $100 Million Financing Deal
-
7:50
Paycase Financial CEO Joseph Weinberg on Bitcoin Technology for Overseas Transactions
-
6:13
NeutriSci is into Energy Tablets, THC, and Genie Bouchard!
-
7:01
Maricann is Expanding Production and Helping Prevent Drug Overdose